Floories 7-OH Tablets feature a premium 7-hydroxymitragynine formulation in a convenient chewable tablet format designed for users seeking concentrated alkaloid content in a compact bottle. Each bottle contains 20 chewable tablets totaling 2,000mg, providing a portable format that's easy to carry, store, and portion throughout the day.
Delivering 100mg of 7-hydroxymitragynine per tablet, each quad-scored tablet can be divided into four 25mg portions for greater serving flexibility. The chewable format requires no powders, capsules, or mixing, while the durable bottle helps keep tablets protected and organized for convenient everyday use or travel.
100mg Per Tablet: Premium 7-hydroxymitragynine formulation in every chewable tablet.
2,000mg Total Per Bottle: Twenty-tablet bottle delivering concentrated total alkaloid content.
Quad-Scored Tablets: Easily divided into four 25mg portions for flexible serving sizes.
Chewable Format: No powders, capsules, or additional preparation required.
Durable Bottle Packaging: Designed to keep tablets protected, organized, and ready for storage, travel, or everyday carry.
This product is not available for shipment to the following states: Alabama, Arkansas, Connecticut, Florida, Indiana, Louisiana, Wisconsin; or the following counties: Sarasota County (Florida), San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi).
FDA DISCLAIMER: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
